Helping Restore Vision in Young Children.
ReAlign is leveraging neuroplasticity for early detection and management of amblyopia.
Detection and Management of Amblyopia
Affecting around 400 million people worldwide, amblyopia or lazy eye is a type of neurodevelopmental disorder that constitutes the largest threat to the vision of children. To address this global issue, we developed ReAlign: a web application which is able to diagnose and treat amblyopia using new advancements in technology.
By combining personalization and gamification, the app creates an engaging experience for children of all ages. ReAlign’s diagnostic aspect has gone through preliminary testing and has shown to be around 93.3% efficient. ReAlign is ready to apply its solution globally, making a significant impact on young individuals and communities worldwide.
Our Mission
Affecting 1 out of every 20 people, amblyopia or lazy eye, is a type of neurodevelopmental disorder that constitutes the largest threat to the vision of children and is caused by abnormal vision development in childhood. There is a plethora of visual function deficits experienced by the amblyopic individual that could affect learning, daily activities and the psychological state of affected children. Therefore, it is essential to get the best treatment during the critical period to avoid severe consequences due to this disorder if not treated early. Amblyopia can be treated and is more responsive to treatment among children younger than 8 years. The current method of treatment for amblyopia is primarily patching.
ReAlign’s diagnostic aspect has gone through three trials of preliminary beta testing and has proven to show a significant increase from 80.6% efficiency to 93.3% efficiency.
Our Team
🔥 Ashish ChettimadaChief Executive Officer
💡 Saumya SharmaChief Financial Officer
🚀 Ojaswi KCChief Marketing Officer
🖥️ Shreeya SharmaChief Data Officer
ReAlign is able to diagnose and treat amblyopia using new advancements in technology. In the treatment aspect of the app, a successful result is when the visual acuity of the amblyopic eye has improved, and the score has increased. The improvement of the amblyopic eye is dependent on the severity range of amblyopia and the consistency in therapeutic exercises.
Beta Product Coming Soon
The final product of ReAlign will be available soon. Register at the form below to sign up for the waitlist to get early access!